기본 콘텐츠로 건너뛰기

Tesla Plunges 14% in a Day—Is the Cause the Feud Between Trump and Musk?

 Tesla’s stock took a staggering 14% nosedive in a single day, shaking the market and wiping out $152 billion in market value as its market capitalization fell below $1 trillion.

The primary reason behind this sudden drop? The escalating feud between former President Donald Trump and Tesla CEO Elon Musk, which has stirred up political and economic uncertainty and left investors on edge.


Trump vs. Musk: The Intensifying Conflict

Musk recently lashed out against Trump’s tax cut policy, criticizing it as “a plan for big corporations.” In response, Trump accused Musk of being “ungrateful” and even hinted that Tesla’s federal contracts could be reconsidered.

Additionally, Musk publicly claimed that Trump’s name appeared in Epstein-related government documents, further inflaming tensions. These political entanglements have raised concerns over potential government subsidy reductions for Tesla, negatively impacting investor sentiment.


Other Factors Behind Tesla’s Stock Decline

Beyond political turmoil, several additional reasons contributed to Tesla’s stock slump:

  1. Potential Repeal of EV Tax Credits:
    JP Morgan warned that Tesla’s annual revenue could shrink by $1.2 billion if Trump’s administration eliminates EV tax credits. Considering Tesla’s automotive business accounts for 78.9% of its total revenue with a gross profit margin of 18.4%, the removal of tax incentives could significantly hurt profitability.

  2. Weak Sales in China and Europe:
    Tesla’s May sales in China plummeted by 36% year-over-year, raising concerns about declining global demand. Meanwhile, in Europe, mounting competition has also weighed on Tesla’s sales figures.

  3. Challenges to the Robo-Taxi Business:
    Tesla’s Robo-Taxi service is set to launch on June 12, 2025, in Austin, Texas, with initial deployment using Model Y vehicles before transitioning to Cybercab autonomous cars. However, federal legislation aimed at easing emissions regulations may cut Tesla’s $2 billion in carbon credit revenue, creating an additional financial strain. With Musk lobbying lawmakers for self-driving regulation reforms, his feud with Trump may pose further obstacles to Tesla’s autonomous taxi expansion.


Conclusion: Buy or Sell Tesla?

Tesla was once considered a Trump-era beneficiary, enjoying tax breaks and subsidies under his administration. However, escalating political tensions between Trump and Musk have prompted many investors to reduce their Tesla holdings amid uncertainty.

With Tesla’s stock down 29.5% year-to-date at $284.7, volatility remains high, meaning that while risks exist, so does the potential for a strong rebound. Despite political headwinds, Tesla’s dominance in self-driving technology could eventually boost its valuation.

Elon Musk remains a high-risk, high-reward visionary, driving breakthroughs with SpaceX, Neuralink, xAI, and Tesla. Tesla is the only publicly traded company among Musk’s ventures, making it a unique investment opportunity in the future technology landscape. Holding some Tesla exposure may be worthwhile for long-term investors betting on innovation. 

댓글

이 블로그의 인기 게시물

Why Did HIMS Stock Crash? A Deep Dive into Digital Healthcare Risks

The digital healthcare industry is growing rapidly, but it comes with significant risks. Recently, U.S.-based telehealth company Hims & Hers Health (HIMS) experienced a sharp stock drop, raising red flags for investors. This post explores HIMS’s business model, recent developments, and future outlook. What is Hims & Hers Health (HIMS)   Hims & Hers Health Inc. is a U.S. digital healthcare company offering a wide range of online health solutions( Hair loss treatment, Skin care, Sexual health, Mental health, Wellness (e.g., sleep aids, vitamins, weight management) ) . Through its platform, users complete a brief questionnaire via website or mobile app, which is reviewed by licensed professionals. If approved, prescriptions are delivered to the customer’s home. Some products are also available over-the-counter.  Why Is HIMS Popular?   HIMS operates on a Direct-to-Consumer (D2C) model , with most products offered via monthly subscriptions . This approach...

📊 Comparing 3 China Tech ETFs: DRAG vs. TIGER China Tech Top10 vs. KODEX China Tech Top10 — Which Strategy Fits You?

With valuations for Chinese tech stocks still appearing attractive, I explored three ETFs that take different strategic approaches to China's growth potential. Previously, I introduced the U.S.-listed DRAG ETF, and recently, Mirae Asset’s TIGER China Tech Top10 and Samsung Asset Management’s KODEX China Tech Top10 were listed on the Korean exchange. All three focus on concentrated portfolios of selected large-cap Chinese tech stocks—but their investment strategies differ significantly , and that’s what I want to highlight. The previous post is linked below ⬇️ China Stock Market Valuation   DRAG ETF : China Tech Leader ETF 1️⃣ Roundhill China Dragons ETF (DRAG) U.S.-listed | Focused investment in select Chinese tech giants AUM : $30.06M (₩41.3B approx., as of June 19, 2025) NAV : $25.01 Volume : 2,293 shares (as of June 12, 2025) Expense Ratio : 0.59% No. of Holdings : 6 Strategy : Active Top Holdings : Tencent, Alibaba, Xiaomi, BYD, Pinduoduo, Meituan 🔎 Key Features ...

Analysis of U.S. Healthcare Trends: Which Sectors Are Thriving?

 The U.S. healthcare industry is evolving rapidly, influenced by policy changes and technological innovation. The restructuring of healthcare under the Trump administration, along with the expansion of Health Services & Technology (HST) and Specialty Pharmacies , are key developments shaping the market. 1. Overview of the U.S. Healthcare System Unlike South Korea, the U.S. does not have a universal national health insurance system . Instead, it operates on a private insurance-driven healthcare model. Healthcare costs in the U.S. are among the highest in the world, and without insurance, patients face exorbitant medical expenses. As a result, private health insurance is essential, and many companies offer employee benefits that include health coverage. This has led to a highly competitive and active private insurance market . As of 2023, 17.6% of the U.S. population is aged 65 or older , and the average life expectancy is 79.3 years . Meanwhile, the mortality rate has decli...